1. Retention of IRB Records
  2. Continuing Review: Submission and Review
  3. Study Closure
  4. Principal Investigator Status for UW–Madison Studies Involving Human Participants
  5. Issues in Human Subjects Research When State Law May Apply
  6. UW–Madison Federalwide Assurance (FWA)
  7. Contact Information for Reporting Suggestions and Concerns
  8. HRPP Guidance, Forms and Resources
  9. Changes in Research Activities: Submission and Review
  10. Noncompliance
  11. HRPP Education and Training
  12. IRB Reliance
  13. Instructions for Completing CITI Human Participants Research Training
  14. Instructions for Linking Previous CITI Training to Your NetID
  15. Human Subjects Research Protection Program (HRPP) Policy Index
  16. HRPP Newsletter - Spring 2018
  17. Human Research Protection Program Newsletter
  18. Institutional Officials in Charge of HRPP
  19. Protecting Research Participants Privacy Interests and Confidentiality of Data
  20. Engagement in Human Participants Research at UW–Madison
  21. Evaluating the Scientific or Scholarly Merits of Proposed Research
  22. Equitable Selection of Research Participants Guidance
  23. Investigating the Cause of Noncompliance and Implementing Corrective and Preventive Action (CAPA) Plans Guidance
  24. Exempt Research
  25. Certificate of Confidentiality (CoC) Application Help
  26. Post-Approval Monitoring Program
  27. Good Clinical Practice (GCP) Training Guidance and Instructions
  28. Human Participants Research Training
  29. Recruitment of Research Participants Guidance
  30. Review of Research Involving Vulnerable Participants
  31. Instructions for Completing CITI Refresher Training
  32. IRB Members’ Conflicts of Interest
  33. Obtaining and Documenting Informed Consent
  34. Clinical Trials Registration & Results Reporting
  35. Additional Requirements When Conducting Human Subjects Research with Environmental Protection Agency (EPA) Support
  36. Creation and Dissemination of Policies and Related Documentation
  37. Application of Federalwide Assurance (FWA) Terms to UW-Madison Human Participants Research Policy
  38. Exempt Research (for non-federally funded, non-FDA-regulated, non-VA research)
  39. Research with Adult Participants Lacking Capacity to Consent
  40. De-Identified Publicly Available Datasets Guidance
  41. IRB Composition and Quality Performance
  42. Reporting to Institutional and External Authorities
  43. Review of Data and Safety Monitoring in Research
  44. Maintenance of IRB Records
  45. ED/SBS IRB Principal Investigator Responsibilities
  46. Good Clinical Practice (GCP) Refresher Instructions
  47. UW HRPP Quality Assurance
  48. Cross-Campus Human Research Protection Program (HRPP) Committee Charter
  49. Office for Human Research Protections (OHRP) - IRB Knowledge of Local Research Context
  50. IRB Review of Study Resources
  51. HRPP Resources for the Public
  52. Exceptions to Informed Consent Requirements in Emergency Situations
  53. List of Approved De-Identified Publicly Available Datasets
  54. Unanticipated Problems
  55. NIH Genomic Data Sharing Policy for Human Data Guidance
  56. Expert Review
  57. FDA IRB Regulations (21 CFR 56)
  58. Compliance with Human Research Protections in Sponsored Research
  59. HRPP and IRB Resources
  60. Campus IT Policies
  61. Preventing Noncompliance Guidance
  62. Single Institutional Review Board (IRB) for Multi-Site Federal Grants Policy
  63. Reporting of Suggestions and Concerns Regarding the Protection of Research Participants
  64. IRB Analysis of Risks and Benefits of Research Guidance
  65. ED/SBS IRB Office Guidance Index
  66. Conflicts of Interest of Non-UW-Madison Key Personnel
  67. Reportable Abuse and Neglect Guidance
  68. Initial Review: Submission and Review Policy
  69. Common Rule (45 CFR 46)
  70. Monitoring the Consent Process
  71. UW-Madison HIPAA Program
  72. Use of Human Fetal Tissue in Research Policy Links
  73. OPRR Guidance on 45 CFR 46.101(b)(5): Exemption for Research and Demonstration Projects on Public Benefit and Service Programs
  74. Reporting of Suggestions and Concerns Regarding HRPP Performance and Function
  75. Suspension and Termination of Approved Research
  76. Developing an Internal Quality Assurance (QA) Program Guidance
  77. OHRP Continuing Review Guidance
  78. OHRP Guidance on Engagement of Institutions in Human Subjects Research
  79. Use of Human Fetal Tissue in Research
  80. IRB Meeting Minutes and Regulatory Documentation
  81. Student Research
  82. Compliance Monitoring and Quality Improvement
  83. IRB Consultants Use and Conflict of Interest
  84. OHRP & FDA Expedited Review Guidance
  85. Considerations for Accepting or Ceding IRB Review Guidance
  86. IRB Meetings
  87. IRB Authority and Independence
  88. IRB Purview
  89. Quality Assurance Committees
  90. Post Approval Monitoring Program Services
  91. UW Post-Approval Monitors
  92. Additional Requirements When Conducting Human Subjects Research with Department of Energy (DOE) Support
  93. Additional Requirements When Conducting Human Subjects Research with Department of Defense (DOD) Support
  94. Human Research Protection Program (HRPP) Newsletter - Spring 2017
  95. Human Research Protection Program (HRPP) Newsletter - Fall 2016
  96. Human Research Protection Program (HRPP) Newsletter - Spring 2016
  97. Additional Requirements When Conducting Human Subjects Research with Department of Justice (DOJ) Support
  98. Additional Requirements When Conducting Human Subjects Research with Department of Education (ED) Support
  99. UW Human Research Protection Program Newsletter - Fall 2015